As for inflammatory mediators, we observed higher serum levels of TNF‐alpha in PBC and NAFLD patients compared with CTRLs, but no differences in IL1‐beta, IL‐6 or IFN‐gamma. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatotic liver disease.